These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 24184111)

  • 1. A hybrid fuzzy-ontology based intelligent system to determine level of severity and treatment recommendation for Benign Prostatic Hyperplasia.
    Torshizi AD; Zarandi MH; Torshizi GD; Eghbali K
    Comput Methods Programs Biomed; 2014; 113(1):301-13. PubMed ID: 24184111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benign prostatic hyperplasia: diagnosis and treatment. Agency for Health Care Policy and Research.
    McConnell JD; Barry MJ; Bruskewitz RC
    Clin Pract Guidel Quick Ref Guide Clin; 1994 Feb; (8):1-17. PubMed ID: 7507389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuro-fuzzy classification of prostate cancer using NEFCLASS-J.
    Keles A; Hasiloglu AS; Keles A; Aksoy Y
    Comput Biol Med; 2007 Nov; 37(11):1617-28. PubMed ID: 17531217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benign prostatic hyperplasia: diagnosis and treatment. Benign Prostatic Hyperplasia Guideline Panel. Agency for Health Care Policy and Research.
    Am Fam Physician; 1994 Apr; 49(5):1157-65. PubMed ID: 7512308
    [No Abstract]   [Full Text] [Related]  

  • 5. A fuzzy expert system for diabetes decision support application.
    Lee CS; Wang MH
    IEEE Trans Syst Man Cybern B Cybern; 2011 Feb; 41(1):139-53. PubMed ID: 20501347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
    Hammarsten J; Högstedt B
    Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
    Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
    J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Dice measure of cubic hesitant fuzzy sets and its initial evaluation method of benign prostatic hyperplasia symptoms.
    Fu J; Ye J; Cui W
    Sci Rep; 2019 Jan; 9(1):60. PubMed ID: 30635593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for disease progression in patients with lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH): a systematic analysis of expert opinion.
    Lowe FC; Batista J; Berges R; Chartier-Kastler E; Conti G; Desgrandchamps F; Dreikorn K; O'Leary M; Perez M; Speakman M; Trachtenberg J; Tubaro A; Meesen B; Smets L; Stoevelaar H
    Prostate Cancer Prostatic Dis; 2005; 8(3):206-9. PubMed ID: 15953934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Benign prostatic hyperplasia and evidence based medicine: its approach in clinical practice].
    Carballido Rodríguez JA; Rodríguez Vallejo JM; del Llano Señaris JE
    Med Clin (Barc); 2000; 114 Suppl 2():96-104. PubMed ID: 10916816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of a model to develop a symptom index for benign prostatic hyperplasia in dogs.
    Zambelli D; Cunto M; Gentilini F
    Reprod Domest Anim; 2012 Dec; 47 Suppl 6():229-31. PubMed ID: 23279506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benign prostatic hyperplasia: a review.
    Ramsey EW
    Can J Urol; 2000 Dec; 7(6):1135-43. PubMed ID: 11151094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of histological prostatitis in patients with urinary retention and underlying benign prostatic hyperplasia or adenocarcinoma of the prostate.
    van Vuuren SP; Heyns CF; Zarrabi AD
    BJU Int; 2012 Apr; 109(8):1194-7. PubMed ID: 21851551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The international system of overall scoring assessment of the symptoms and quality of life of patients with benign prostatic hyperplasia].
    Trapeznikova MF; Bazaev VV; Golubev GV; Mezentsev VA
    Urol Nefrol (Mosk); 1996; (2):2-4. PubMed ID: 8677545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH).
    Gandaglia G; Briganti A; Gontero P; Mondaini N; Novara G; Salonia A; Sciarra A; Montorsi F
    BJU Int; 2013 Aug; 112(4):432-41. PubMed ID: 23650937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic modeling to assess the costs of treatment with finasteride, terazosin, and transurethral resection of the prostate for men with moderate to severe symptoms of benign prostatic hyperplasia.
    Lowe FC; McDaniel RL; Chmiel JJ; Hillman AL
    Urology; 1995 Oct; 46(4):477-83. PubMed ID: 7571214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The natural history of benign prostatic hyperplasia.
    Harv Mens Health Watch; 1998 Mar; 2(8):1-5. PubMed ID: 9516320
    [No Abstract]   [Full Text] [Related]  

  • 18. Benign prostatic hyperplasia: a brief overview of pathogenesis, diagnosis, and therapy.
    Priest R; Garzotto M; Kaufman J
    Tech Vasc Interv Radiol; 2012 Dec; 15(4):261-4. PubMed ID: 23244721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating risk profiles for disease progression in the treatment choice for patients with lower urinary tract symptoms/benign prostatic hyperplasia: a combined analysis of external evidence and clinical expertise.
    Speakman M; Batista J; Berges R; Chartier-Kastler E; Conti G; Desgrandchamps F; Dreikorn K; Lowe F; O'Leary M; Perez M; Trachtenberg J; Tubaro A; Meesen B; Smets L; Stoevelaar H
    Prostate Cancer Prostatic Dis; 2005; 8(4):369-74. PubMed ID: 16130013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and risk of treatment for benign prostatic hyperplasia in Japanese men: a 15-year longitudinal community-based study.
    Fukuta F; Masumori N; Mori M; Tsukamoto T
    Int J Urol; 2013 Jan; 20(1):100-6. PubMed ID: 23106204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.